Clinical Trial Environmental Impact
CMC Ontology
Data FAIRy Bioassay Annotation
Global Substance Registration System
IDMP Ontology
In Vitro NAM Data Standards
In Vitro Pharmacology
Large Language Models in Life Sciences
NLP Use Case Database
Pharma General Ontology
Social Media Real World Evidence
Current Projects
Delivered Projects
AI / ML
CSCS
Data Governance
FAIR
Lab of the Future
Microbiome-Mediated Drug Metabolism Database
Quantum Computing
UXLS
Current Communities
Delivered Communities
Delivered Projects and Communities
New Ideas
Username or Email Address
Password
Remember Me
Webinar
Software as a medical device (SaMD) that leverages artificial intelligence (AI) has the opportunity to reshape healthcare. It also raises unique challenges for developers and regulators. As healthcare advances and digital solutions leveraging AI become more prevalent, it is important that medical device regulatory frameworks also advance to match the speed of innovation.
Bayer and Roche are leading biopharmaceutical companies, which each have a diverse and distributed ecosystem of platforms to manage data and metadata used by different parts of each organization. This webinar will present the technical details for each platform.
This webinar will present clinical data standardization and harmonization using the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), standard vocabularies, and standardized analytics.
Federated learning is a new machine-learning paradigm where multiple partners can collaborate on complex research questions without centralizing or sharing data outside of their organizations.
Join Genentech and Optibrium for this discussion of Alchemite™, a novel deep learning approach, and its application to optimizing kinase profiling programs. Using Alchemite™ reduces the number of kinase assays required to accurately predict the full kinase selectivity profile, effectively accelerating experimental programs
This session will dive into how the double-diamond design philosophy manifests into diverse user research artifacts and methods for structuring and synthesizing these artifacts in a centralized research database like Airtable to facilitate the design process and extend their value to the rest of your organization.
There is an increasing number of reports discussing the urgent need for addressing bias in decision-making algorithms in healthcare. In this webinar industry experts will share lessons learned and discuss possible solutions.
In 2020, a team of scientists from AstraZeneca, Bristol Myers Squibb, Novartis, and Roche set forth to find a way to convert unstructured biological assay descriptions into FAIR information objects.
Roche, as a leading biopharmaceutical company, has a diverse and distributed ecosystem of platforms to manage reference data standards used at different parts of the organization. Lynx is a FAIR-fueled system to enable seamless access across that ecosystem.
This presentation will provide practical recommendations on how to put the tsunami of RWE and data variety to work using the IMPACT framework.
Imaging biomarkers are an ideal method for drawing evidence from retrospective data and can be used both as inclusion criteria, to select relevant cohorts of patients, and as output data, to quantify responses to treatments
